120 related articles for article (PubMed ID: 18355014)
1. Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent.
Norek M; Kampert E; Zeitler U; Peters JA
J Am Chem Soc; 2008 Apr; 130(15):5335-40. PubMed ID: 18355014
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
[TBL] [Abstract][Full Text] [Related]
3. Cobalt nanoparticles as a novel magnetic resonance contrast agent--relaxivities at 1.5 and 3 Tesla.
Parkes LM; Hodgson R; Lu le T; Tung le D; Robinson I; Fernig DG; Thanh NT
Contrast Media Mol Imaging; 2008; 3(4):150-6. PubMed ID: 18756588
[TBL] [Abstract][Full Text] [Related]
4. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
[TBL] [Abstract][Full Text] [Related]
5. Dysprosium and Holmium Vanadate Nanoprobes as High-Performance Contrast Agents for High-Field Magnetic Resonance and Computed Tomography Imaging.
Gómez-Gónzalez E; Núñez NO; Caro C; García-Martín ML; Fernández-Afonso Y; de la Fuente JM; Balcerzyk M; Ocaña M
Inorg Chem; 2021 Jan; 60(1):152-160. PubMed ID: 33201695
[TBL] [Abstract][Full Text] [Related]
6. Toward design of magnetic nanoparticle clusters stabilized by biocompatible diblock copolymers for T₂-weighted MRI contrast.
Balasubramaniam S; Kayandan S; Lin YN; Kelly DF; House MJ; Woodward RC; St Pierre TG; Riffle JS; Davis RM
Langmuir; 2014 Feb; 30(6):1580-7. PubMed ID: 24479874
[TBL] [Abstract][Full Text] [Related]
7. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
8. Synthetic antiferromagnetic nanoparticles as potential contrast agents in MRI.
Van Roosbroeck R; Van Roy W; Stakenborg T; Trekker J; D'Hollander A; Dresselaers T; Himmelreich U; Lammertyn J; Lagae L
ACS Nano; 2014 Mar; 8(3):2269-78. PubMed ID: 24483137
[TBL] [Abstract][Full Text] [Related]
9. Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theory.
Vuong QL; Van Doorslaer S; Bridot JL; Argante C; Alejandro G; Hermann R; Disch S; Mattea C; Stapf S; Gossuin Y
MAGMA; 2012 Dec; 25(6):467-78. PubMed ID: 22790646
[TBL] [Abstract][Full Text] [Related]
10. Key Parameters on the Microwave Assisted Synthesis of Magnetic Nanoparticles for MRI Contrast Agents.
Brollo MEF; Veintemillas-Verdaguer S; Salván CM; Morales MDP
Contrast Media Mol Imaging; 2017; 2017():8902424. PubMed ID: 29348738
[TBL] [Abstract][Full Text] [Related]
11. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
[TBL] [Abstract][Full Text] [Related]
12. Ni-Fe2O4 nanoparticles as contrast agents for magnetic resonance imaging.
Ahmad T; Rhee I; Hong S; Chang Y; Lee J
J Nanosci Nanotechnol; 2011 Jul; 11(7):5645-50. PubMed ID: 22121585
[TBL] [Abstract][Full Text] [Related]
13. Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.
Cowger TA; Tang W; Zhen Z; Hu K; Rink DE; Todd TJ; Wang GD; Zhang W; Chen H; Xie J
Theranostics; 2015; 5(11):1225-32. PubMed ID: 26379788
[TBL] [Abstract][Full Text] [Related]
14. Holmium phosphate nanoparticles as negative contrast agents for high-field magnetic resonance imaging: Synthesis, magnetic relaxivity study and in vivo evaluation.
Gómez-González E; Caro C; Martínez-Gutiérrez D; García-Martín ML; Ocaña M; Becerro AI
J Colloid Interface Sci; 2021 Apr; 587():131-140. PubMed ID: 33360885
[TBL] [Abstract][Full Text] [Related]
15. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging.
Das GK; Johnson NJ; Cramen J; Blasiak B; Latta P; Tomanek B; van Veggel FC
J Phys Chem Lett; 2012 Feb; 3(4):524-9. PubMed ID: 26286058
[TBL] [Abstract][Full Text] [Related]
16. Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: synthesis, characterization, and in vivo application.
Tegafaw T; Xu W; Ahmad MW; Baeck JS; Chang Y; Bae JE; Chae KS; Kim TJ; Lee GH
Nanotechnology; 2015 Sep; 26(36):365102. PubMed ID: 26291827
[TBL] [Abstract][Full Text] [Related]
17. Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles.
McDonald MA; Watkin KL
Acad Radiol; 2006 Apr; 13(4):421-7. PubMed ID: 16554221
[TBL] [Abstract][Full Text] [Related]
18. Ligand-size dependent water proton relaxivities in ultrasmall gadolinium oxide nanoparticles and in vivo T1 MR images in a 1.5 T MR field.
Kim CR; Baeck JS; Chang Y; Bae JE; Chae KS; Lee GH
Phys Chem Chem Phys; 2014 Oct; 16(37):19866-73. PubMed ID: 25123195
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-based hybrid nanoparticles as a positive MR contrast agent.
Hifumi H; Yamaoka S; Tanimoto A; Citterio D; Suzuki K
J Am Chem Soc; 2006 Nov; 128(47):15090-1. PubMed ID: 17117851
[TBL] [Abstract][Full Text] [Related]
20. Labeling of cancer cells with magnetic nanoparticles for magnetic resonance imaging.
Weis C; Blank F; West A; Black G; Woodward RC; Carroll MR; Mainka A; Kartmann R; Brandl A; Bruns H; Hallam E; Shaw J; Murphy J; Teoh WY; Aifantis KE; Amal R; House M; Pierre TS; Fabry B
Magn Reson Med; 2014 May; 71(5):1896-905. PubMed ID: 23813415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
